Desang diabetes magazine diabetes news

NEWS

SUGAR BEAT DUE TO LAUNCH

OUTSTANDING CALIFORNIAN STEM CELL SITE

Nemaura has developed predictive

algorithms to support alarm functions in its

wearable SugarBeat glucose monitoring

system. The British company's device has

alarm functionality that can predict a user's

glucose level five minutes in advance with

98% accuracy, 10 minutes in advance

with 95% accuracy and 15 minutes in

advance with 90% accuracy, according

to research. Researchers found that data

from the SugarBeat product compared

favourably with data gleaned from other

CGM systems. Nemaura is expecting to

win CE Mark approval soon, at which

point it will launch in the UK with a small

group of users which will then be followed

up with a full scale launch on a gradual

basis across the UK and into other major

European territories.

Nemaura Pharma is a UK based

specialist Biotech Company with over 20

products in development, including several

complex injectables, using proprietary

and differentiated delivery platforms.

The Company is head-quartered in the

University town of Loughborough, and

has several development laboratories

as well as a clean room suite and a

license for the manufacture and supply

of transdermal, topical, and aseptically

manufactured injectable products using

gassed isolation technology.

An 'Outstanding Innovation' award has been

won by Now Healthcare Group (NHG). The

digital health company has been selected as

'The Most Outstanding Bespoke Healthcare

Innovation in the World in 2018', by the

Globals. This is one of the highest accolades

designated by the annual healthcare

industry awards recognising innovation

in the world of health. Now Healthcare

Group are pioneers at the forefront of

the health care revolution and its digital

innovation is empowering NHS patients'

by giving them the choice to access GP

video consultations, (via bespoke mobile

technology) and the ease of ordering their

prescriptions, from the comfort of their

home or workplace. Earlier this year, NHG

opened a new £1.5m digital Pharmacy,

which has been kitted out with the

optimum robotic technology to streamline

processes and service and fulfil medicines

for thousands of patients. NHG work with

millions of people across the world and

provide GP consultations, medical advice

and prescriptions for employees of many

corporate clients, including Aviva.

www.nowhealthcaregroup.com

Novo Nordisk has announced the

establishment of a manufacturing site in

California to develop and produce stem

cell-based therapies, the company having

signed a long-term lease on a facility. The

site will support the company's increased

commitment to develop stem-cell based

therapies within Type 1 diabetes (and

other serious chronic diseases).

Due to be operational in 2019, the

facility will supply of stem cell-based

therapies for Novo Nordisk's clinical trial

programmes. Jacob Sten Petersen,

corporate vice president and head of

Stem Cell Research & Development

(R&D), Novo Nordisk, says: "Our ambition

is to develop stem cell-based therapies

for a range of serious chronic diseases

where we see significant unmet medical

need. The reliable, large-scale supply

of therapies is a vital component in

our efforts, so I am delighted that we

have established this facility that further

demonstrates our strong commitment to

this field."

Stem cell-based therapy is emerging

as a treatment option for a number

We previously covered the technology

in our June 2016 issue (page 12), in an

article called Kit That's Coming Soon.

www.nemaura.co.uk

of serious chronic diseases. It has the

potential to provide novel treatments for

diseases with high unmet medical needs

where no or inadequate therapy exists.

Pluripotent stem cells have an unlimited

capacity for self-renewal and the potential

to be differentiated into any specialised

cell type in the body. The Novo Nordisk

stem cell technology platform is based

on human embryonic stem cells (hESC)

that can be used for generation of cell

products for a wide range of therapeutic

indications.

Novo Nordisk's R&D in this field

is anchored in its recently established

Stem Cell Transformational Research

Unit, based in Måløv, Denmark. The unit

oversees multiple partnership projects

pursuing stem cell-based treatments for

diabetes, Parkinson's disease, chronic

heart failure and dry age-related macular

degeneration (AMD). The new production

facility will directly support these projects,

enabling the future expansion of Novo

Nordisk's stem cell research portfolio into

the clinic.

www.novonordisk.com

Index

  1. Desang diabetes magazine diabetes information
  2. Abbott Freestyle Libre, Flash Glucose Monitoring, blood testing without lancets
  3. Desang diabetes magazine diabetes information, Sue Marshall
  4. Desang diabetes magazine diabetes news
  5. Desang diabetes magazine diabetes news
  6. Desang diabetes magazine diabetes news
  7. Dexcom CGM, continuous glucose monitoring
  8. Desang diabetes magazine diabetes news
  9. OneTouch Sports weekend, diabetes and exercise
  10. Ascensia art gallery World Diabetes day 2018 the family
  11. Ascensia Contour Next One Diabetes blood test meters
  12. Desang diabetes magazine Quality in Care diabetes awards
  13. Desang diabetes magazine Quality in Care diabetes awards
  14. Medtronic diabetes insulin pump, Medtronic Minimed 640G
  15. London Medical, London Diabetes Centre, private diabetes clinic
  16. Diabetes kit diabetes management equipment
  17. Medtrum diabetes technology, Medtrum insulin patch pump, insulin pump, CGM
  18. Desang diabetes magazine diabetes diet
  19. Desang diabetes magazine diabetes diet
  20. Accu-Chek Mobile blood glucose system
  21. Accu-Chek Mobile blood glucose system
  22. Desang diabetes magazine, digital detox, keep fit eat fit, angela coffey diabetes
  23. Desang diabetes magazine, digital detox, keep fit eat fit
  24. Desang diabetes magazine, digital detox, keep fit eat fit
  25. Omnipod Insulet insulin pump with insulin pods, podders
  26. Desang diabetes magazine, behaviour change, Our Path
  27. Desang diabetes magazine, behaviour change, Our Path
  28. Desang diabetes magazine, behaviour change, Our Path
  29. OurPath programme, Roche Diabetes Care
  30. Desang diabetes magazine, behaviour change, Our Path
  31. Medtronic Minimed 670G insulin pump
  32. Desang diabetes magazine, My Diabetes Kit, Paul Longley
  33. Desang diabetes magazine, My Diabetes Kit, Paul Longley
  34. Input Diabetes technology
  35. Desang diabetes kitbags
  36. Desang diabetes magazine, Abbott Freestyle Libre sensor
  37. Desang diabetes magazine, Abbott Freestyle Libre sensor
  38. Desang diabetes magazine, Abbott Freestyle Libre sensor
  39. Desang diabetes magazine, Abbott Freestyle Libre sensor
  40. Making Carbs Count the science of spice Dr Stuart Farrimond
  41. Making Carbs Count the science of spice Dr Stuart Farrimond
  42. Accu-Chek Insight insulin pump
  43. Accu-Chek Insight insulin pump
  44. Free diabetes magazine, living with diabetes, the diabetic diet, carb counting

Related Issues